Literature DB >> 17957943

Salmonella gas-forming femoral osteomyelitis and pyomyositis: the first case and review of the literature.

Opass Putcharoen1, Chusana Suankratay.   

Abstract

The authors describe the first case of Salmonella serogroup D gas-forming femoral osteomyelitis and pyomyositis in a 51-year-old man with non-Hodgkin lymphoma. The patient was successfully treated with surgical debridement as well as clindamycin plus ceftriaxone, and then switched to ciprofloxacin. However, he eventually died due to multidrug-resistant Acinetobacter baumannii pneumonia. In addition, five cases of Salmonella gas-forming pyomyositis in the literature were reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957943

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

Review 1.  Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis.

Authors:  M Gousseff; F Lanternier; A Ferroni; O Chandesris; N Mahlaoui; O Hermine; O Lortholary; M Lecuit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-01       Impact factor: 3.267

2.  Emphysematous osteomyelitis of the clavicle: a pleural process?

Authors:  Amira Elshikh; Niraj Gowda; Lisa Glass; Robert B Maximos
Journal:  BMJ Case Rep       Date:  2020-07-28

3.  Extraintestinal Salmonellosis in the Immunocompromised: An Unusual Case of Pyomyositis.

Authors:  Veeraraghavan Meyyur Aravamudan; Phang Kee Fong; Pavel Singh; Jong Sze Chin; Yang Shiyao Sam; P A Tambyah
Journal:  Case Rep Med       Date:  2017-09-11

4.  Dry Gangrene in Children with Typhoid Intestinal Perforation: A Report of Two Cases.

Authors:  Lofty-John C Anyanwu; Aminu M Mohammad; Lawal B Abdullahi; Mustapha U Ibrahim; Aliyu U Farinyaro; Mohammed S Aliyu; Stephen K Obaro
Journal:  Case Rep Surg       Date:  2018-10-08

5.  Emphysematous Osteomyelitis of the Spine: A Case Report and Literature Review.

Authors:  Ryohei Ono; Koji Uehara; Izumi Kitagawa
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.